Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer: Complete Statistical AnalysisIndependent statistical analysis of Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode: Complete Statistical AnalysisIndependent statistical analysis of Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation: Complete Statistical AnalysisIndependent statistical analysis of Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome): Complete Statistical AnalysisIndependent statistical analysis of Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS): Complete Statistical AnalysisIndependent statistical analysis of Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36): Complete Statistical AnalysisIndependent statistical analysis of Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36): primary endpoint results, effect…
- Long-Term Follow-up Study of ADVM-043: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Follow-up Study of ADVM-043: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03804021).
- Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): Complete Statistical AnalysisIndependent statistical analysis of Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Long-term Open-Label Safety Study to Evaluate EN3409: Complete Statistical AnalysisIndependent statistical analysis of Long-term Open-Label Safety Study to Evaluate EN3409: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755546).
- Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy: Complete Statistical AnalysisIndependent statistical analysis of Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Long-term Outcomes After Percutaneous Closure of PFO: Complete Statistical AnalysisIndependent statistical analysis of Long-term Outcomes After Percutaneous Closure of PFO: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05558774).
- Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals’ Hepatitis B Vaccine (HBV), Engerix-B: Complete Statistical AnalysisIndependent statistical analysis of Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-Term Retention of Gadolinium in Bone: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Retention of Gadolinium in Bone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01853163).
- Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain: Complete Statistical AnalysisIndependent statistical analysis of Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004: Complete Statistical AnalysisIndependent statistical analysis of Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE): Complete Statistical AnalysisIndependent statistical analysis of Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson’s Disease (PDD): Complete Statistical AnalysisIndependent statistical analysis of Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD): primary endpoint results, effect estimate with confidence interval, sample-size…
- Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine: Complete Statistical AnalysisIndependent statistical analysis of Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Long-Term Safety Study of Tafenoquine: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study of Tafenoquine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03320174).
- Long-Term Study of Nitisinone to Treat Alkaptonuria: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Study of Nitisinone to Treat Alkaptonuria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00107783).
- Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients: Complete Statistical AnalysisIndependent statistical analysis of Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB: Complete Statistical AnalysisIndependent statistical analysis of Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease): Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02356211).
- Longitudinal Surveillance Registry (LSR) of ACUITY Spiral: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Surveillance Registry (LSR) of ACUITY Spiral: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00955708).
- Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan: Complete Statistical AnalysisIndependent statistical analysis of Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LOSSIndependent statistical analysis of LOSS- Louisiana Obese Subjects Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00115063).
- Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LOTUSDIIndependent statistical analysis of A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LOVARBIndependent statistical analysis of Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Lovastatin in Treating Patients At High Risk of Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Lovastatin in Treating Patients At High Risk of Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00462280).
- Lovaza® and Microvascular Function in Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Lovaza® and Microvascular Function in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00931879).
- Loving-Kindness Meditation for PTSD: Complete Statistical AnalysisIndependent statistical analysis of Loving-Kindness Meditation for PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01962714).
- LOVIT IIIndependent statistical analysis of Low Vision Intervention Trial II (LOVIT II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00958360).
- Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01428128).
- Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00970073).